Coagulation-fibrinolysis abnormalities in poststroke patients.

Coagulation-fibrinolysis abnormalities in poststroke patients.

We thank Drs Shahar, McGovern, and Spraflca for their interest in our paper in which we demonstrated, inter alia, that low doses of aspirin may not be as efficacious as higher doses. Our sample population was indeed matched, and Shahar et al are correct in pointing out that analysis for data obtained according to a matched design should have been performed. However, it is possible to ignore mat...

Coagulation-Fibrinolysis Abnormalities in Poststroke Patients

We thank Drs Shahar, McGovern, and Spraflca for their interest in our paper in which we demonstrated, inter alia, that low doses of aspirin may not be as efficacious as higher doses. Our sample population was indeed matched, and Shahar et al are correct in pointing out that analysis for data obtained according to a matched design should have been performed. However, it is possible to ignore mat...

Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.

BACKGROUND AND PURPOSE We studied the activities of the coagulation-fibrinolysis system in the chronic stage of poststroke patients and the effect of antiplatelet medication on the system. METHODS We determined fibrinogen, antithrombin III, thrombin-antithrombin III complex, tissue plasminogen activator antigen, plasminogen activator inhibitor-1, plasmin-alpha 2 plasmin inhibitor complex, and...

Coagulation and Fibrinolysis Abnormalities in Patients with Muscular Dystrophy

Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy.

OBJECTIVE Familial amyloid polyneuropathy (FAP) is an autosomal dominant form of hereditary amyloidosis. Several studies reported coagulation factor X deficiency and excessive fibrinolysis in immunoglobulin light chain amyloidosis. However, few have investigated coagulation and fibrinolysis in FAP. The objective of this study was to determine abnormalities in plasma biomarkers of coagulation an...